SCHEMBL9948623

SCHEMBL9948623

CC1C[C@H]2C(=CC1=O)CC[C@@H]1[C@@H]2CC[C@]2(C)CCC[C@@H]12

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 7/20 0.44
▸ SHBG P04278 2/20 0.41
▸ SERPINA6 P08185 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ SLC22A1 O15245 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ MBOAT4 Q96T53 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6301569 0.86 CYP19A1 (0.44) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL4945163 0.86 SHBG (0.48) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL3356889 0.86 CYP19A1 (0.44) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL9947828 0.84 CYP19A1 (0.42) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL8370954 0.83 CYP19A1 (0.41) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL9948721 0.83 CYP19A1 (0.41) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL7702311 0.81 CYP19A1 (0.67) CYP19A1SHBGSERPINA6ALDH1A1LMNA
SCHEMBL10449145 0.81 CYP19A1 (0.39) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL6244893 0.81 SERPINA6 (0.41) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1
SCHEMBL19608861 0.81 CYP19A1 (0.66) CYP19A1SHBGSERPINA6ALDH1A1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207150-B2 17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative Bayer Pharma AG (DE) 2012-06-26 — — US disclosed
Send feedback